CK Life Sciences Int'l., (Holdings) Inc.

DB:LSI Stock Report

Market Cap: €486.9m

CK Life Sciences Int'l. (Holdings) Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:LSI Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
11 Nov 24Buy€117,048Lance Richard Lee YuenIndividual2,130,000€0.055
06 Nov 24Buy€2,944Lance Richard Lee YuenIndividual54,000€0.055
05 Nov 24Buy€6,221Lance Richard Lee YuenIndividual116,000€0.054

Insider Trading Volume

Insider Buying: LSI insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of LSI?
Owner TypeNumber of SharesOwnership Percentage
Institutions33,945,6670.353%
Private Companies717,257,4297.46%
Individual Insiders2,135,843,28622.2%
General Public2,368,392,04824.6%
Public Companies4,355,634,57045.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 16 shareholders own 75.36% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
45.3%
CK Hutchison Holdings Limited
4,355,634,570€220.7m0%no data
22.1%
Ka-shing Li
2,119,318,286€107.4m0%no data
7.45%
Triluck Assets Limited
716,441,429€36.3m0%no data
0.29%
Dimensional Fund Advisors LP
28,061,667€1.4m0.08%no data
0.065%
Hing Lam Kam
6,225,000€315.4k0%no data
0.049%
BlackRock, Inc.
4,680,000€237.1k10.4%no data
0.024%
Lance Richard Lee Yuen
2,300,000€116.5k0%no data
0.023%
Tzar Kuoi Li
2,250,000€114.0k0%no data
0.023%
Edmond Tak Chuen IP
2,250,000€114.0k0%no data
0.023%
Ying Choi Yu
2,250,000€114.0k0%no data
0.011%
Peter Peace Tulloch
1,050,000€53.2k0%no data
0.0085%
Whole New Enterprises Limited
816,000€41.3k0%no data
0.0061%
Northern Trust Global Investments
584,000€29.6k0%no data
0.0058%
Pictet Asset Management SA
560,000€28.4k0%no data
0.0021%
Eva Kwok
200,000€10.1k0%no data
0.00062%
American Century Investment Management Inc
60,000€3.0k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/29 02:32
End of Day Share Price 2024/12/27 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CK Life Sciences Int'l., (Holdings) Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jayaprabha DhavaleVirtua Research Inc.